Galen Pharmaceuticals Limited, a active public limited company, was established on 06 February 1990 in Baroda, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232GJ1990PLC013327. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.64 M.
Formerly known as Galen Pharmaceuticals Pvt Ltd. It upholds a active non-compliant status. Employing 13 professional, Its leadership includes Harsh Pravinkumar Patel (Director), Shardaben Pravin Patel (Director), Aakash Pravinkumar Patel (Director). Past directors included Harsh Pravinkumar Patel, Aakash Pravinkumar Patel, Khodabhai Haribhai Patel. It holds ₹2.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 334/5 Gidc Estatewaghodia Road, Baroda, Gujarat, 391760.
U24232GJ1990PLC013327
013327
06 February 1990
₹5.00 M
₹0.64 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Galen Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harsh Pravinkumar Patel | Director | 08 Mar 2016 | Current |
| Shardaben Pravin Patel | Director | 06 Feb 1990 | Current |
| Aakash Pravinkumar Patel | Director | 14 Feb 2015 | Current |
| Pravinkumar Karsandas Patel | Director | 06 Feb 1990 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 23 Aug 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Galen Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.98% decrease. The company also saw a slight decrease in profitability, with a 4.11% decrease in profit. The company's net worth Soared by an impressive increase of 29.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Galen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,466,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Mar 2023 | Hdfc Bank Limited | ₹1.00 M | Open |
| 01 Aug 2022 | Hdfc Bank Limited | ₹2.00 M | Open |
| 28 Dec 2021 | Bank Of India | ₹1.35 M | Open |
| 11 Nov 2006 | State Bank Of India | ₹1.60 Cr | Open |
| 24 Jul 1998 | Dena Bank | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Galen Pharmaceuticals has a workforce of 13 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Galen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Galen Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Galen Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.00 M with Charge ID 100710739 was registered on 01 Mar 2023. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 2.00 M with Charge ID 100644225 was registered on 01 Aug 2022. was recorded as a recent event.
The activity A charge with Bank Of India amounted to Rs. 1.35 M with Charge ID 100519870 was registered on 28 Dec 2021. was completed.
The activity Harsh Pravinkumar Patel was appointed as a Director was appointed as a Director on 08 Mar 2016 & has been associated with this company since 9 years 9 months . was completed.
The CIN of Galen Pharmaceuticals Limited is U24232GJ1990PLC013327.
Galen Pharmaceuticals Limited is headquartered at 334/5 Gidc Estatewaghodia Road, Baroda, Gujarat, 391760.
Galen Pharmaceuticals Limited was incorporated on 06 February 1990.
The current directors of Galen Pharmaceuticals Limited are
The primary industry of Galen Pharmaceuticals Limited is Manufacturing.
Galen Pharmaceuticals Limited is unlisted.
The authorized capital of Galen Pharmaceuticals Limited is ₹5.00 M, and the paid-up capital is ₹0.64 M.
The compliance status of Galen Pharmaceuticals Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX